Indo US Bio-Tech Ltd. benchmarking: Perfomance to industry peers

Financial

	Indo US Bio-Tech	Kotyark Industries	Nath Bio-Genes
Operational Metrics
Financials
5 yr Average ROE	17.08 %	22.18 %	5.32 %
5yr average Equity Multiplier	1.63	1.4	1.7
5yr Average Asset Turnover Ratio	0.98	2.45	0.47
5yr Avg Net Profit Margin	11.14 %	8.23 %	3.69 %
Price to Book	2.82	0.0	0.45
P/E	14.42	17.48	6.94
5yr Avg Cash Conversion Cycle	-322.69 Days	113.93 Days	624.86 Days
Inventory Days	144.07 Days	67.28 Days	233.68 Days
Days Receivable	59.84 Days	32.35 Days	91.63 Days
Days Payable	195.14 Days	0.07 Days	-735.53 Days
5yr Average Interest Coverage Ratio	6.57	12.26	2.84
5yr Avg ROCE	18.82 %	28.83 %	11.39 %
5yr Avg Operating Profit Margin	13.97 %	14.45 %	14.56 %
5 yr average Debt to Equity	0.36	0.35	0.21
5yr CAGR Net Profit	45.1 %	20.77 %	26.86 %
5yr Average Return on Assets	10.87 %	16.72 %	2.21 %
Shareholdings
Promoter Holding	70.17 %	67.76 %	45.6 %
Share Pledged by Promoters	0.0	0.0	13.78 %
Change in Promoter Holding (3 Yrs)	-3.85 %	-4.46 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	-3.86 %

	Indo US Bio-Tech	Kotyark Industries	Nath Bio-Genes
Product Wise Break-Up	Product Wise Break-Up Vegetable Seeds 0 Plant Nutrient Suplement 0 Foundation Seeds 0 Commercial Seeds 0 Others 100	Product Wise Break-Up Plant Nutrient Suplement 0 Commercial Seeds 0 Vegetable Seeds 0 Foundation Seeds 0 Others 100	Product Wise Break-Up Plant Nutrients 10.05 Commercial Seeds 86.98 Vegetable Seeds 2.45 Foundation Seeds 0 Others 0.52